dihexa pnb-0408 c-met hgfr activator Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology Nrf2 Independent Anti Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




